Internal Medicine
Partner With Us
Advertisement
Conexiant chevron_right Internal Medicine chevron_right Latest Headlines

Latest Headlines

thumb description

July 24, 2026

FDA Approves Ophthalmic Bevacizumab

The approval establishes the first and only FDA-approved ophthalmic formulation of bevacizumab for neovascular age-related macular degeneration in the US.

Conexiant

thumb description

July 24, 2026

FDA Approves Furoscix ReadyFlow

Clinical data demonstrated achievement of the primary pharmacokinetic endpoint, with urine output and sodium and potassium excretion comparable with those observed with intravenous furosemide, according to MannKind.

Conexiant

thumb description

July 24, 2026

Addressing Gaps in HCV Treatment Data

Investigators found that laboratory and pharmacy data each offered useful measures of hepatitis C care, although combining both provided the most complete assessment.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

thumb description

July 23, 2026

New Data for Acquired Hypothalamic Obesity

Researchers found greater reductions in body mass index and participant-reported hunger scores with setmelanotide than with placebo, although adverse and serious adverse events were more frequent in the setmelanotide group; only one serious adverse event was considered treatment-related.

Conexiant